________________
Form
8-K
________________
|
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of
the
Securities Exchange Act of 1934
|
Date
of Report (Date of Earliest Event Reported): February 4,
2010
|
Micrus
Endovascular Corporation
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-51323
|
23-2853441
|
||
(State
or Other Jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
||
of
Incorporation)
|
Identification
No.)
|
821
Fox Lane, San Jose, California
|
95131
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(408)
433-1400
(Registrant’s
Telephone Number, Including Area Code)
|
Item
2.02.
|
Results
of Operations and Financial
Condition.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit
|
Description
|
|
99.1
|
Press
Release dated February 4, 2010.
|
MICRUS
ENDOVASCULAR CORPORATION
(Registrant)
|
|
Date:
February 4, 2010
|
By: /s/
Gordon T.
Sangster
Gordon T. Sangster
Chief Financial Officer
|
Exhibit
|
Description
|
|
99.1
|
Press
Release dated February 4, 2010
|